95 related articles for article (PubMed ID: 10788573)
1. Ocular changes in beagle dogs following oral administration of CGS 24565, a potential hypolipidemic agent.
Schiavo DM; Bentley P
Toxicol Sci; 2000 May; 55(1):189-94. PubMed ID: 10788573
[TBL] [Abstract][Full Text] [Related]
2. Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits.
Kadar T; Turetz J; Fishbine E; Sahar R; Chapman S; Amir A
Curr Eye Res; 2001 Jan; 22(1):42-53. PubMed ID: 11402378
[TBL] [Abstract][Full Text] [Related]
3. Tapetal changes in beagle dogs following oral administration of CGS 14796C, a potential aromatase inhibitor.
Schiavo DM; Green JD; Traina VM; Spaet R; Zaidi I
Fundam Appl Toxicol; 1988 Feb; 10(2):329-34. PubMed ID: 3356320
[TBL] [Abstract][Full Text] [Related]
4. Clinical progression of ocular injury following arsenical vesicant lewisite exposure.
Tewari-Singh N; Croutch CR; Tuttle R; Goswami DG; Kant R; Peters E; Culley T; Ammar DA; Enzenauer RW; Petrash JM; Casillas RP; Agarwal R
Cutan Ocul Toxicol; 2016 Dec; 35(4):319-28. PubMed ID: 27002633
[TBL] [Abstract][Full Text] [Related]
5. Ocular toxicity in beagle dogs with lortalamine, a non tricyclic antidepressant compound.
Mally C; Thiebault JJ
Drug Chem Toxicol; 1990; 13(4):309-23. PubMed ID: 2279460
[TBL] [Abstract][Full Text] [Related]
6. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Tsujinaka A; Takai Y; Inoue Y; Tanito M
Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
[No Abstract] [Full Text] [Related]
7. Area and depth of surfactant-induced corneal injury predicts extent of subsequent ocular responses.
Jester JV; Petroll WM; Bean J; Parker RD; Carr GJ; Cavanagh HD; Maurer JK
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2610-25. PubMed ID: 9856771
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization.
Goswami DG; Tewari-Singh N; Dhar D; Kumar D; Agarwal C; Ammar DA; Kant R; Enzenauer RW; Petrash JM; Agarwal R
Cornea; 2016 Feb; 35(2):257-66. PubMed ID: 26555588
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Modeling of Corneal Alkali Injury in the Rat Eye.
Choi H; Phillips C; Oh JY; Stock EM; Kim DK; Won JK; Fulcher S
Curr Eye Res; 2017 Oct; 42(10):1348-1357. PubMed ID: 28636415
[TBL] [Abstract][Full Text] [Related]
10. Ocular injury progression and cornea histopathology from chloropicrin vapor exposure: Relevant clinical biomarkers in mice.
Ebenezar OO; Roney A; Goswami DG; Petrash JM; Sledge D; Komáromy AM; Liby KT; Tewari-Singh N
Exp Eye Res; 2023 May; 230():109440. PubMed ID: 36933694
[TBL] [Abstract][Full Text] [Related]
11. The corneal fibrosis response to epithelial-stromal injury.
Torricelli AA; Santhanam A; Wu J; Singh V; Wilson SE
Exp Eye Res; 2016 Jan; 142():110-8. PubMed ID: 26675407
[TBL] [Abstract][Full Text] [Related]
12. Quantitative characterization of acid- and alkali-induced corneal injury in the low-volume eye test.
Jester JV; Molai A; Petroll WM; Parker RD; Carr GJ; Cavanagh HD; Maurer JK
Toxicol Pathol; 2000; 28(5):668-78. PubMed ID: 11026602
[TBL] [Abstract][Full Text] [Related]
13. Corneal neovascularization and ocular irritancy responses in dogs following topical ocular administration of an EP4-prostaglandin E2 agonist.
Aguirre SA; Huang W; Prasanna G; Jessen B
Toxicol Pathol; 2009 Dec; 37(7):911-20. PubMed ID: 20008547
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and Molecular Changes in the Rabbit Cornea From Arsenical Vesicant Lewisite Exposure.
Tewari-Singh N; Goswami DG; Kant R; Ammar DA; Kumar D; Enzenauer RW; Casillas RP; Croutch CR; Petrash JM; Agarwal R
Toxicol Sci; 2017 Dec; 160(2):420-428. PubMed ID: 28973427
[TBL] [Abstract][Full Text] [Related]
15. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.
Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625
[TBL] [Abstract][Full Text] [Related]
16. Studies of the toxicological potential of tripeptides (L-valyl-L-prolyl-L-proline and L-isoleucyl-L-prolyl-L-proline): IV. Assessment of the repeated-dose toxicological potential of synthesized L-valyl-L-prolyl-L-proline in male and female rats and dogs.
Nakamura Y; Bando I; Mennear JH; Bernard BK
Int J Toxicol; 2005; 24 Suppl 4():25-39. PubMed ID: 16419577
[TBL] [Abstract][Full Text] [Related]
17. Ocular injuries following sulfur mustard exposure--pathological mechanism and potential therapy.
Kadar T; Dachir S; Cohen L; Sahar R; Fishbine E; Cohen M; Turetz J; Gutman H; Buch H; Brandeis R; Horwitz V; Solomon A; Amir A
Toxicology; 2009 Sep; 263(1):59-69. PubMed ID: 19061933
[TBL] [Abstract][Full Text] [Related]
18. Ocular changes induced in the beagle dog by intravenous infusion of a novel dopaminergic compound, FPL 65447.
Kerry PJ; Wakefield ID; Evans JG
Toxicol Pathol; 1993; 21(3):274-82. PubMed ID: 7902612
[TBL] [Abstract][Full Text] [Related]
19. Corn1: a mouse model for corneal surface disease and neovascularization.
Smith RS; Hawes NL; Kuhlmann SD; Heckenlively JR; Chang B; Roderick TH; Sundberg JP
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):397-404. PubMed ID: 8603845
[TBL] [Abstract][Full Text] [Related]
20. Transient downregulation of microRNA-206 protects alkali burn injury in mouse cornea by regulating connexin 43.
Li X; Zhou H; Tang W; Guo Q; Zhang Y
Int J Clin Exp Pathol; 2015; 8(3):2719-27. PubMed ID: 26045777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
